https://www.selleckchem.com/pr....oducts/dl-ap5-2-apv.
5%) were diagnosed with major birth defects as compared with 36 (3.7%) among the matched unexposed pregnancies (prevalence OR, 0.94; 95% CI 0.59, 1.52). Exposure to 4-aminoquinolines in pregnancy was neither associated with an increased risk of preterm birth (prevalence OR, 0.97; 95% CI 0.73, 1.28) or SGA (prevalence OR, 1.18; 95% CI 0.93, 1.5, compared with unexposed pregnancies. No significant associations between exposure to chloroquine or HCQ individually and risk of the outcomes were identified. Among pregnancies exposed to